Stada
| STADA Arzneimittel AG
|
|
|---|---|
 |
|
| legal form | Corporation |
| ISIN | DE0007251803 |
| founding | 1895 |
| Seat |
Bad Vilbel , Germany
|
| management |
|
| Number of employees | 10,416 |
| sales | 2.3 billion euros (2018) |
| Branch | Pharmaceutical manufacturer |
| Website | www.stada.com/de |
| As of December 31, 2018 | |
The Stada Arzneimittel Aktiengesellschaft (spelling: STADA ) is a German pharmaceutical company with headquarters in Bad Vilbel , which specializes in the production of generics and non-prescription pharmaceuticals . Well-known products are, in addition to the high-selling generics paracetamol and lactulose , the Parkinson's drug Apo-Go , the combination preparation for colds Grippostad C , the sunscreen Ladival and the anti-inflammatory / analgesic Mobilat .
history
Stada was founded in Dresden in 1895 as a cooperative of pharmacists . Stada is the abbreviation for Standard Drugs of German Pharmacists . After the Second World War , the company was relocated to Essen and Tübingen , and in 1956 another move to Bad Vilbel was due. In 1970 the Stada was converted into a stock corporation. At that time, shares were only issued to pharmacists as registered shares with restricted transferability . Five years later, Stada began entering the business with generic drugs whose patent protection had expired ( generics ). In 1986 Stada began to expand internationally and bought or founded companies in Switzerland and Austria . A short time later, further foreign branches were set up in the Netherlands and Belgium (1991) as well as in Asia (1992). As a second mainstay, the company acquired the generics distributor Aliud Pharma in 1996 and expanded further to France and the Czech Republic. Via Aliud Pharma as a cooperation partner, Stada has a connection to a practice program for doctors.
As of July 23, 2001, the company was included in the MDAX , where it remained until June 18, 2018. Until 2006, further foreign acquisitions were made in Denmark , Spain , Italy , Great Britain , Russia , Serbia , Portugal and Asia. In January 2009 the Danish pharmaceutical company Dermalog ApS was taken over.
In 2015, the company achieved sales of 2.1 billion euros with 10,532 employees at the end of the year. In June 2016, long-time CEO Hartmut Retzlaff left the company. This was preceded by a publication about its interrelationships. In August 2016, the chairman of the supervisory board, Martin Abend, was voted out of office in a general meeting lasting more than thirteen hours . In April 2017, Stada signed an agreement for a takeover by a consortium of investment firms Bain Capital and Cinven . For their entry into force, the previous shareholders would have had to offer the consortium a quota of at least 75% of the shares (later reduced to 67.5%), which, however, was barely achieved by the end of the deadline on June 26, 2017. As a result, the Chairman of the Board of Management Matthias Wiedenfels and the Board Member for Finance, Marketing and Sales, Helmut Kraft, resigned from their offices. Stada transferred the chairmanship and marketing and sales departments to Engelbert Coster Tjeenk Willink on an interim basis until the end of the year; Bernhard Düttmann became the new CFO.
Production facilities
Stada pharmaceutical production facilities in Europe are located in:
- Bad Vilbel (Germany)
- Banja Luka (Bosnia-Herzegovina)
- Clonmel (Ireland)
- Dobovac , Šabac and Vršac (Serbia)
- Moscow (two locations), Nizhny Novgorod , Obninsk and in the Ryazan Oblast (Russia)
- Podgorica (Montenegro)
In Asia, production takes place in the following locations:
- Beijing (People's Republic of China)
- Ho Chi Minh City (two locations) (Vietnam)
Shareholder structure
The financial investor Bain Capital holds a majority of 93.67% . (As of November 2018) The remaining 6 percent are in free float .
Web links
Individual evidence
- ↑ a b Annual Report 2018. Stada, March 19, 2019, accessed on May 29, 2019.
- ↑ Data-AL GmbH: Cooperation partner of Data-AL GmbH
- ↑ STADA Arzneimittel AG: Annual Report 2015. Retrieved on August 1, 2016 .
- ^ Patrick Hollstein: System Retzlaff: Family Business. Retrieved July 5, 2016 .
- ↑ Press release: Change in the Management Board of STADA Arzneimittel AG. Retrieved July 5, 2016 .
- ↑ Siegfried Hofmann, Jakob Blume: Revolution in hour 13 . In: Handelsblatt , August 27, 2016, accessed on February 15, 2017.
- ↑ Takeover burst Stada share price plummeting. June 27, 2017. Retrieved May 29, 2019 .
- ↑ BaFin - Significant shares of voting rights according to Sections 33, 38 and 39 of the Securities Trading Act (WpHG). In: bafin.de. Retrieved December 3, 2019 .